Details
- Identification
- ISBN 978-92-9469-632-8, Catalogue number EA-02-23-177-EN-N
- Publication date
- 19 December 2023
- Author
- European Innovation Council and SMEs Executive Agency
- Publication type
- Case study
Description
This case study showcases how the ground-breaking research of Professor Vincenzo Cerullo and his group at the ImmunoViroTherapy Lab at Helsinki University led to the founding of the spin-out company Valo Therapeutics (ValoTx), setting out to make cancer immunotherapy more effective and accessible to patient.
Files
ValoTx: Developing Personalised Immunotherapies for Cancer